Other approaches, such as pro- inflammatory cytokines and costimulatory ... previously a challenge for conditionally activated agents. Werewolf completed its $56 million Series A financing in ...

Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. have announced a strategic research collaboration within the field of conditionally activated ... such as cytokines and checkpoint ...

MaveriX Oncology has developed the IMPACT-2X platform for the design of first-in-class small-molecule therapeutics—which are conditionally activated by highly expressed hydroxylases in cancer ...